This article is available to subscribers. Subscribe now. Already have an account? Sign in

Medical IntelligenceFree PreviewArchive

Sulfisoxazole as Chemoprophylaxis for Recurrent Otitis Media — A Double-Blind Crossover Study in Pediatric Practice

List of authors.
  • James M. Perrin, M.D.,
  • Evan Charney, M.D.,
  • James B. MacWhinney, Jr., M.D.,
  • Thomas K. McInerny, M.D.,
  • Robert L. Miller, M.D.,
  • and Lawrence F. Nazarian, M.D.

ACUTE otitis media is a common problem in pediatric practice. Its incidence in the first decade of life is usually reported to be 10 to 20 episodes per 100 children per year,1 , 2 with an even higher incidence in certain high-risk populations.3 , 4 The epidemiology of recurrent otitis media has not been extensively studied although the tendency to recurrences is marked, especially among younger children. Approximately half those with otitis during a one-year period will have had at least one previous attack.1 , 2 Prospectively, 20 per cent of patients with acute otitis will suffer at least one recurrence in three years.5 The main . . .

Funding and Disclosures

Supported in part by a grant (148–10) from the Children's Bureau.

We are indebted to Dr. Richard Robertson for the microbiological analyses and to Messrs. Luis Hernandez and Bruce Winters and Mrs. Jane Boutet for the coding and packaging of the sulfisoxazole and placebo preparations.

Author Affiliations

From the Rochester Collaborative Research Group, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, 260 Crittenden Blvd., Rochester, NY 14642, where reprint requests should be addressed to Dr. Perrin.

Print Subscriber? Activate your online access.